| Theme | Abnormal Blood Pressure in Dialysis Patients | |
|---|---|---|
| Title | Anti-hypertensive therapy for hemodialysis patients | |
| Publish Date | 2011/08 | |
| Author | Hideki Takizawa | Department of Nephrology, Teinekeijinkai Hospital |
| Author | Nobuyuki Ura | Department of Internal Medicine, Teinekeijinkai Hospital |
| Author | Izumi Yamaji | Department of Nephrology, Teinekeijinkai Hospital |
| Author | Tamaki Takada | Department of Nephrology, Teinekeijinkai Hospital |
| [ Summary ] | There is a paucity of prospective data to support information regarding appropriate blood pressure (BP) targets. Anti-hypertensive therapy for hemodialysis patients consists of a combination of volume control and vasodilation. Fluid volume management consists of constant dry weight adjustment and maintenance of urine output. Renin-angiotensin inhibitors, β blockers and calcium antagonists are first-line drugs for hemodialysis patients. Alpha blockers, central antihypertensive drugs and combinations of angiotensin converting enzyme inhibitor (ACEI) and angiotensin II receptor blockers (ARB) medications should be considered. | |